Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.73 |
| ▸ | HPGD | P15428 | 1/20 | 0.73 |
| ▸ | RAB9A | P51151 | 1/20 | 0.73 |
| ▸ | KCNK3 | O14649 | 4/20 | 0.71 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.68 |
| ▸ | NAMPT | P43490 | 1/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.65 |
| ▸ | MEN1 | O00255 | 2/20 | 0.65 |
| ▸ | HTT | P42858 | 1/20 | 0.65 |
| ▸ | KCNK9 | Q9NPC2 | 2/20 | 0.62 |
| ▸ | GAA | P10253 | 1/20 | 0.61 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23447715 | 0.85 | NPC1 (1.00) | NPC1HPGDRAB9AKCNK3SMN1; SMN2 | |
| SCHEMBL12021948 | 0.83 | KCNK3 (0.87) | KCNK3SMN1; SMN2KMT2AMEN1HTT | |
| SCHEMBL2991678 | 0.83 | KCNK3 (0.74) | NPC1HPGDRAB9AKCNK3SMN1; SMN2 | |
| SCHEMBL29354335 | 0.83 | KCNK3 (0.74) | NPC1HPGDRAB9AKCNK3SMN1; SMN2 | |
| SCHEMBL28185509 | 0.82 | NPC1 (0.76) | NPC1HPGDRAB9AKCNK3SMN1; SMN2 | |
| SCHEMBL29817931 | 0.81 | NPC1 (0.62) | NPC1HPGDRAB9AKCNK3NAMPT | |
| SCHEMBL20379678 | 0.81 | NAMPT (1.00) | NAMPT | |
| SCHEMBL11083807 | 0.81 | KCNK3 (0.82) | RAB9AKCNK3SMN1; SMN2KMT2AMEN1 | |
| SCHEMBL22699755 | 0.81 | KCNK3 (0.77) | KCNK3SMN1; SMN2KMT2AMEN1HTT | |
| SCHEMBL14345056 | 0.81 | KCNK3 (0.71) | KCNK3SMN1; SMN2KMT2AMEN1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119001775-B | Efficient capturing method suitable for short burst signals of low-orbit satellite | 湖南跨线桥航天科技有限公司 | 2025-02-07 | — | — | CN | claimed |
| CN-222196528-U | Multi-channel high-flow serial NPMF membrane element | 西安领伯环保科技有限公司 | 2024-12-20 | — | — | CN | claimed |
| CN-119001775-A | Efficient capturing method suitable for short burst signals of low-orbit satellite | 湖南跨线桥航天科技有限公司 | 2024-11-22 | — | — | CN | claimed |
| CN-116647251-B | Signal acquisition method suitable for MC-CDMA system | 天地信息网络研究院(安徽)有限公司 | 2023-10-03 | — | — | CN | claimed |
| CN-116647251-A | Signal capturing method suitable for MC-CDMA system with low signal to noise ratio and large frequency offset | 天地信息网络研究院(安徽)有限公司 | 2023-08-25 | — | — | CN | claimed |
| US-20260075511-A1 | AUTHORIZATION, CREATION, AND MANAGEMENT OF PERSONAL NETWORKS | INTERDIGITAL PATENT HOLDINGS, INC. (US) | 2026-03-12 | — | — | US | disclosed |
| EP-4027735-B1 | MEASURING ACCESS NETWORK PERFORMANCE FOR A MULTI-ACCESS DATA CONNECTION | LENOVO SINGAPORE PTE LTD (SG) | 2025-11-26 | — | — | EP | disclosed |
| US-12376027-B2 | Authorization, creation, and management of personal networks | INTERDIGITAL PATENT HOLDINGS, INC. (US) | 2025-07-29 | — | — | US | disclosed |
| US-20250203433-A1 | METHODS, APPARATUS, AND SYSTEMS FOR PROVIDING INFORMATION TO WTRU VIA CONTROL PLANE OR USER PLANE | INTERDIGITAL PATENT HOLDINGS, INC. (US) | 2025-06-19 | — | — | US | disclosed |
| WO-2025065347-A1 | SYSTEM AND METHOD FOR REALIZING SENSING SERVICE | 深圳TCL新技术有限公司 | 2025-04-03 | — | — | WO | disclosed |
| CN-119001775-B | Efficient capturing method suitable for short burst signals of low-orbit satellite | 湖南跨线桥航天科技有限公司 | 2025-02-07 | — | — | CN | disclosed |
| EP-4500928-A1 | METHODS, APPARATUS, AND SYSTEMS FOR PROVIDING INFORMATION TO WTRU VIA CONTROL PLANE OR USER PLANE | InterDigital Patent Holdings, Inc. (US) | 2025-02-05 | — | — | EP | disclosed |
| WO-2023028527-A1 | AUTHORIZATION, CREATION, AND MANAGEMENT OF PERSONAL NETWORKS | INTERDIGITAL PATENT HOLDINGS, INC. (US) | 2023-03-02 | — | — | WO | disclosed |
| CN-217947817-U | Nano plane membrane wastewater treatment system | 西安领伯环保科技有限公司 | 2022-12-02 | — | — | CN | disclosed |
| US-20220303830-A1 | MEASURING ACCESS NETWORK PERFORMANCE FOR A MULTI-ACCESS DATA CONNECTION | LENOVO (SINGAPORE) PTE. LTD. (SG) | 2022-09-22 | — | — | US | disclosed |
| US-11445335-B2 | Systems and methods for enabling private communication within a user equipment group | HUAWEI TECHNOLOGIES CO., LTD. (CN) | 2022-09-13 | — | — | US | disclosed |
| EP-4027735-A1 | MEASURING ACCESS NETWORK PERFORMANCE FOR A MULTI-ACCESS DATA CONNECTION | Lenovo (Singapore) Pte. Ltd. (SG) | 2022-07-13 | — | — | EP | disclosed |
| US-11356897-B2 | Measuring access network performance for a multi-access data connection | LENOVO (SINGAPORE) PTE. LTD. (SG) | 2022-06-07 | — | — | US | disclosed |
| CN-112586004-B | Systems, methods, and media for enabling private communication within a group of user equipment | 华为技术有限公司 | 2022-04-29 | — | — | CN | disclosed |
| EP-3797554-B1 | MEASURING ACCESS NETWORK PERFORMANCE FOR A MULTI-ACCESS DATA CONNECTION | LENOVO SINGAPORE PTE LTD (SG) | 2022-04-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260075511-A1 | AUTHORIZATION, CREATION, AND MANAGEMENT OF PERSONAL NETWORKS | NCDN, NMUR2, HNRNPU | NPC1 3210/4885HPGD 3134/4885RAB9A 2579/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.